Sign In
Buy TARA
$3.92
-0.110 (-2.73%)
At Close: Jul 31, 2026
Here's Why Protara Therapeutics (TARA) Is a Great 'Buy the Bottom' Stock Now
10:56am, Friday, 12'th Apr 2024
Protara Therapeutics (TARA) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions cou
Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing
08:04am, Friday, 05'th Apr 2024
Anticipated net proceeds, along with existing cash and cash equivalents, expected to extend cash runway into 2026 Anticipated net proceeds, along with existing cash and cash equivalents, expected to e
NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, tod
Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC
08:00am, Friday, 05'th Apr 2024
NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, tod
3 Stocks That Could Help You Retire on a Private Island
06:00am, Saturday, 23'rd Mar 2024
If you want to strike it rich via stocks to help you retire on a private island, the reality is this: You probably can't go the buy-and-hold approach that legendary investors like Warren Buffett deplo
Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
08:00am, Wednesday, 13'th Mar 2024
NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, tod
Protara Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
08:00am, Wednesday, 28'th Feb 2024
NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, toda
Protara Therapeutics to Participate in Upcoming Investor Conferences
07:30am, Wednesday, 31'st Jan 2024
NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, toda
NEW YORK, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, toda
Protara Therapeutics Announces Third Quarter 2023 Financial Results and Business Update
08:00am, Friday, 03'rd Nov 2023
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, toda
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, toda
Dosing is progressing on schedule in ongoing ADVANCED-1EXP trial evaluating TARA-002 in NMIBC patients with CIS; preliminary results expected in 1H24 Dosing is progressing on schedule in ongoing ADVAN
Protara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
07:30am, Tuesday, 05'th Sep 2023
NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, tod
Protara Therapeutics Announces Second Quarter 2023 Financial Results and Business Update
08:00am, Thursday, 03'rd Aug 2023
NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, toda
Protara Therapeutics to Participate in Upcoming Investor Conferences
08:00am, Wednesday, 01'st Mar 2023
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, tod
